Bonolact Pro + femina capsule. Oral dietary supplement with natural vaginal flora bacteria for women. A preparation containing active bacteria Lactobacillus rhamnosus, GR-1®, and Lactobacillus reuteri, RC-14®. Active ingredient content: in 1 capsule (daily dose) Lactobacillus reuteri (RC-14®); at least 2 billion CFU*; Lactobacillus rhamnosus (GR-1®): at least 2 billion CFU* (*Colony-forming unit)

The vagina is an extremely sensitive organ. Even everyday things can upset the balance of its microflora and cause unpleasant symptoms. Lactobacillus dominates the natural vaginal flora of healthy adult women. The bacteria in Bonolact Pro+femina capsule are part of the natural microflora of the vagina.

Ingredients: maltodextrin, capsule material (hydroxypropyl methylcellulose), bulking agent: microcrystalline cellulose; active bacteria: Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®; anti-caking agent: magnesium stearate.

Gluten-, lactose*-, gelatine- and milk protein-free, suitable for vegetarian and vegan diets. (*Lactose content <0.1 g / 100 g.)

Ingredient list valid at the time of publication.
Always check the product packaging for accurate information!

Dosage: For oral use! 1 capsule daily with meals. During antibiotic treatment, it is recommended to take Bonolact Pro+femina capsules at least 3 hours after taking the medicine.

Warning: People who are sensitive to the ingredients of the product should not consume the product! Not recommended for use under 4 years of age. The product does not replace a balanced diet and a healthy lifestyle. Do not exceed the recommended consumption amount. Keep out of reach of children!

Storage: In original packaging, in a dry place protected from light, at a temperature not exceeding 25 °C.

Manufacturer: Hungarian Dairy Experimental Institute Ltd. ; 9200 Mosonmagyaróvár, Csiszár József utca 1. www.mtki.hu

Distributor: Rubenza Ltd. 1112 Budapest, Repülőtéri út. 2/a. www.rubenza.hu.

Lactobacillus rhamnosus, GR-1®, and Lactobacillus reuteri, RC-14® are registered by Chr Hansen A/S